These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 8501569
21. Quercetin, an over-the-counter supplement, causes neuroblastoma-like elevation of plasma homovanillic acid. Weldin J, Jack R, Dugaw K, Kapur RP. Pediatr Dev Pathol; 2003; 6(6):547-51. PubMed ID: 15018454 [Abstract] [Full Text] [Related]
22. Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma. Galli S, Naranjo A, Van Ryn C, Tilan JU, Trinh E, Yang C, Tsuei J, Hong SH, Wang H, Izycka-Swieszewska E, Lee YC, Rodriguez OC, Albanese C, Kitlinska J. Am J Pathol; 2016 Nov; 186(11):3040-3053. PubMed ID: 27743558 [Abstract] [Full Text] [Related]
25. Neuropeptide Y secretion from a human insulinoma. Waeber G, Hurlimann J, Haefliger JA, Gomez F, Nicod P, Grouzmann E. J Endocrinol Invest; 1996 Mar 22; 19(3):190-5. PubMed ID: 8743287 [Abstract] [Full Text] [Related]
26. Age dependence and prognostic impact of neuron specific enolase (NSE) in children with neuroblastoma. Berthold F, Engelhardt-Fahrner U, Schneider A, Schumacher R, Zieschang J. In Vivo; 1991 Mar 22; 5(3):245-7. PubMed ID: 1893081 [Abstract] [Full Text] [Related]
27. [Characteristics of urinary excretion of vanilmandelic and homovanillic acids in cases of neuroblastoma during therapy]. Lamedica G, Falcone R, De Bernardi B, Canini S. Minerva Pediatr; 1978 Jan 31; 30(2):137-46. PubMed ID: 642879 [No Abstract] [Full Text] [Related]
28. Clinical validation of urine 3-methoxytyramine as a biomarker of neuroblastoma and comparison with other catecholamine-related biomarkers. Lam L, Woollard GA, Teague L, Davidson JS. Ann Clin Biochem; 2017 Mar 31; 54(2):264-272. PubMed ID: 27235704 [Abstract] [Full Text] [Related]
29. Urinary homovanillic and vanillylmandelic acid in the diagnosis of neuroblastoma: report from the Italian Cooperative Group for Neuroblastoma. Barco S, Gennai I, Reggiardo G, Galleni B, Barbagallo L, Maffia A, Viscardi E, De Leonardis F, Cecinati V, Sorrentino S, Garaventa A, Conte M, Cangemi G. Clin Biochem; 2014 Jun 31; 47(9):848-52. PubMed ID: 24769278 [Abstract] [Full Text] [Related]
30. Plasma dopa and catecholamines in the diagnosis and follow-up of children with neuroblastoma. Alvarado CS, Faraj BA, Kim TH, Camp VM, Bain RP, Ragab AH. Am J Pediatr Hematol Oncol; 1985 Jun 31; 7(3):221-7. PubMed ID: 3934994 [Abstract] [Full Text] [Related]
31. Analytical validation and clinical application of urinary vanillylmandelic acid and homovanillic acid by LC-MS/MS for diagnosis of neuroblastoma. Shen Y, Li H, Lu J, Luo X, Guan Q, Cheng L. Biomed Chromatogr; 2019 Jun 31; 33(6):e4484. PubMed ID: 30632178 [Abstract] [Full Text] [Related]
32. Neuropeptide Y (NPY) as a tumor marker. Priø TK, Hippe E, Christensen NJ. Eur J Haematol; 1993 Oct 31; 51(4):253. PubMed ID: 8243615 [No Abstract] [Full Text] [Related]
33. [Sensitivity and specificity of the determination of urinary catecholamines and their acid metabolites in the diagnosis of neuroblastoma in children]. Horsmans Y, Desager JP, Harvengt C. Bull Cancer; 1990 Oct 31; 77(10):985-9. PubMed ID: 2249018 [Abstract] [Full Text] [Related]
34. Diagnostic and prognostic markers in infants with disseminated neuroblastoma: a retrospective analysis from the Italian Cooperative Group for Neuroblastoma. Di Cataldo A, Dau D, Conte M, Parodi S, De Bernardi B, Giuliano M, Pession A, Viscardi E, Luksch R, Castellano A, Bertuna G, Haupt R, Italian Cooperative Group for Neuroblastoma. Med Sci Monit; 2009 Jan 31; 15(1):MT11-8. PubMed ID: 19114976 [Abstract] [Full Text] [Related]
35. Effect of age on homovanillic and 4-hydroxy-3-methoxymandelic acid levels in plasma. Hunneman DH, Jonas W, Gabriel M, Gahr M. Eur J Pediatr; 1986 Dec 31; 145(6):555-7. PubMed ID: 3816861 [Abstract] [Full Text] [Related]
36. Interchangeability between 24-hour collection and single spot urines for vanillylmandelic and homovanillic acid levels in the diagnosis of neuroblastoma. Cangemi G, Barco S, Reggiardo G, Viscardi E, Di Cataldo A, Garaventa A, Melioli G, Conte M. Pediatr Blood Cancer; 2013 Dec 31; 60(12):E170-2. PubMed ID: 23813598 [Abstract] [Full Text] [Related]
37. Combined measurements of plasma aromatic L-amino acid decarboxylase and DOPA as tumour markers in diagnosis and follow-up of neuroblastoma. Boomsma F, Ausema L, Hakvoort-Cammel FG, Oosterom R, Man in't Veld AJ, Krenning EP, Hahlen K, Schalekamp MA. Eur J Cancer Clin Oncol; 1989 Jul 31; 25(7):1045-52. PubMed ID: 2503383 [Abstract] [Full Text] [Related]
38. Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factors. Georgantzi K, Sköldenberg EG, Stridsberg M, Kogner P, Jakobson Å, Janson ET, Christofferson RHB. Pediatr Hematol Oncol; 2018 Mar 31; 35(2):156-165. PubMed ID: 29737901 [Abstract] [Full Text] [Related]
39. Neuropeptide Y gene polymorphism and plasma neuropeptide Y level in febrile seizure patients in Taiwan. Lin LC, Lin HS, Yang RC. Kaohsiung J Med Sci; 2007 Nov 31; 23(11):560-5. PubMed ID: 18055304 [Abstract] [Full Text] [Related]
40. Conjugated versus "free" acidic metabolites of catecholamines in random urine samples: significance for the diagnosis of neuroblastoma. Tuchman M, Stoeckeler JS. Pediatr Res; 1988 Jun 31; 23(6):576-9. PubMed ID: 3393388 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]